Streetbeat News

Analyst Ratings

HUBS

HubSpot (NYSE:HUBS) has received mixed analyst ratings over the past three months, with a recent decrease in the average price target by 7.69%. Despite positive revenue growth, HubSpot faces challenges with profitability and returns on equity and assets. Analysts have adjusted their ratings and price targets in response to these dynamics.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 4:00 pm

SPRY

ARS Pharmaceuticals (NASDAQ:SPRY) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased to $26.43. The company has shown significant revenue growth but struggles with profitability.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 4:00 pm

ARMK

Analysts have provided mixed ratings for Aramark (NYSE:ARMK), with a recent positive shift in price targets. The average 12-month price target increased by 9.48% to $39.85. Analysts have raised their ratings, reflecting a more optimistic outlook. Despite this, Aramark's financial performance shows challenges, with below-average net margin, ROE, and ROA compared to industry peers.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 4:00 pm

ABT

Abbott Laboratories (NYSE:ABT) is experiencing significant growth in its MedTech portfolio, with a CAGR of 11%-13%, and its non-MedTech operations are expanding at a slower pace. Oppenheimer analyst Suraj Kalia has initiated coverage with an Outperform rating and a price target of $130, citing the company's strong product pipeline and strategic acquisitions. Abbott's shares rose by 0.7% to $114.17.

Portfolio Pulse from Priya Nigam

October 08, 2024 | 3:59 pm

BK

UBS analyst Brennan Hawken has maintained a Buy rating on Bank of New York Mellon (NYSE:BK) and increased the price target from $73 to $82.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:59 pm

BFAM

UBS analyst Joshua Chan maintains a Neutral rating on Bright Horizons Family Solutions (NYSE:BFAM) but raises the price target from $128 to $145.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:57 pm

HOOD

Robinhood Markets, Inc. (NASDAQ:HOOD) shares rose after announcing its first investor day on Dec. 4, 2024, where it will share its vision for the next decade. Barclays raised its price target for HOOD from $20 to $23. Additionally, Dan Gallagher, Robinhood's Chief Legal Officer, is considered for the SEC Chairman position.

Portfolio Pulse from Erica Kollmann

October 08, 2024 | 3:57 pm

AVNW

Lake Street analyst Jaeson Schmidt maintains a Buy rating on Aviat Networks but lowers the price target from $51 to $45.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:55 pm

MORN

Morningstar shares rose following UBS's initiation of coverage with a Buy rating and a $390 price target.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:50 pm

ARMK

UBS analyst Joshua Chan maintains a Buy rating on Aramark and raises the price target from $40 to $44.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:49 pm